Compounds useful as reversible inhibitors of cysteine proteases
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds. 
Boehringer Ingelheim Pharmaceuticals, Inc.
C C A C A C C A C C A C C A C C A C C A A C C A C C A C A
C07D C07D A61P C07D A61P C07D C07D A61P C07D C07D A61P C07D C07D A61P C07D C07D A61P C04B C07D A61P A61P C07D C07D A61P C07D C07D A61P C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Sanxing Weimin Michel Jose Denice Mary David S. Yancey David
Sun Liu Emmanuel Spero Thomson Ward